These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiovascular consequences of early-onset growth hormone excess. Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly. Colao A; Marzullo P; Ferone D; Spinelli L; Cuocolo A; Bonaduce D; Salvatore M; Boerlin V; Lancranjan I; Lombardi G J Clin Endocrinol Metab; 2000 Sep; 85(9):3132-40. PubMed ID: 10999798 [TBL] [Abstract][Full Text] [Related]
4. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly. Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056 [TBL] [Abstract][Full Text] [Related]
5. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582 [TBL] [Abstract][Full Text] [Related]
6. Effect of octreotide pretreatment on surgical outcome in acromegaly. Colao A; Ferone D; Cappabianca P; del Basso De Caro ML; Marzullo P; Monticelli A; Alfieri A; Merola B; Calì A; de Divitiis E; Lombardi G J Clin Endocrinol Metab; 1997 Oct; 82(10):3308-14. PubMed ID: 9329359 [TBL] [Abstract][Full Text] [Related]
7. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464 [TBL] [Abstract][Full Text] [Related]
8. The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Thuesen L; Christensen SE; Weeke J; Orskov H; Henningsen P Clin Endocrinol (Oxf); 1989 Jun; 30(6):619-25. PubMed ID: 2591060 [TBL] [Abstract][Full Text] [Related]
9. Octreotide treatment increases exercise capacity in patients with acromegaly. Padayatty SJ; Perrins EJ; Belchetz PE Eur J Endocrinol; 1996 May; 134(5):554-9. PubMed ID: 8664974 [TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Giustina A; Boni E; Romanelli G; Grassi V; Giustina G Am J Cardiol; 1995 May; 75(15):1042-7. PubMed ID: 7747686 [TBL] [Abstract][Full Text] [Related]
11. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555 [TBL] [Abstract][Full Text] [Related]
12. Cardiac effect of thyrotoxicosis in acromegaly. Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177 [TBL] [Abstract][Full Text] [Related]
13. Octreotide as primary therapy for acromegaly. Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397 [TBL] [Abstract][Full Text] [Related]
15. Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics. Minniti G; Jaffrain-Rea ML; Moroni C; Baldelli R; Ferretti E; Cassone R; Gulino A; Tamburrano G Clin Endocrinol (Oxf); 1998 Jul; 49(1):101-6. PubMed ID: 9797853 [TBL] [Abstract][Full Text] [Related]